Ketamine Recall: STAQ Pharma, 50 mg/5 mL injection
Announced 2025-10-22 · FDA
FDA recall notice: STAQ Pharma, Inc. is recalling Ketamine Hydrochloride injection due to labeling issues involving incorrect or missing lot and/or expiration dates. Affected lots are 25102464B (Exp 26NOV2025), 25102370A (Exp 20OCT2025), and 25102369A (Exp 19OCT2025). The recall is nationwide in the U.S.; no corrective action is listed.
| Brand | STAQ Pharma, Inc. |
|---|---|
| Product | FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05. |
| Reason | Labeling: Incorrect or Missing Lot and/or Exp Date |
| Severity | low |
| Distribution | Nationwide in the U.S. |
| Agency | FDA |
| Recall / campaign no. | Lot: 25102464B, Expiry: 26NOV2025; 25102370A, Expiry: 20OCT2025; 25102369A, Expiry: 19OCT2025. |
WHAT YOU SHOULD DO
- Do not use any recalled Ketamine Hydrochloride injection; set aside affected lots.
- Check your product’s lot number and expiry date against the recall details: 25102464B (Exp 26NOV2025), 25102370A (Exp 20OCT2025), 25102369A (Exp 19OCT2025).
- Contact your healthcare provider, hospital, or supplier for replacement or return instructions.
- If you used the product or notice adverse effects, contact your clinician and report to the FDA MedWatch program.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.